当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Drug Metabolism and Disposition杂志
Drug Metabolism and Disposition
基本信息
期刊名称 Drug Metabolism and Disposition
DRUG METAB DISPOS
期刊ISSN 0090-9556
期刊官方网站 http://dmd.aspetjournals.org/
是否OA No
出版商 American Society for Pharmacology and Experimental Therapeutics
出版周期 Monthly
文章处理费 登录后查看
始发年份 1973
年文章数 157
影响因子 4.4(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学2区 PHARMACOLOGY & PHARMACY 药学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 6.5 0.941 1.060
Pharmacology, Toxicology and Pharmaceutics
Pharmaceutical Science
52/183 71%
Pharmacology, Toxicology and Pharmaceutics
Pharmacology
105/313 66%
补充信息
自引率 15.9%
H-index 161
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0090-9556%5BISSN%5D
投稿指南
期刊投稿网址 http://submit-dmd.aspetjournals.org/
收稿范围
Drug Metabolism and Disposition will consider for publication manuscripts describing the results of original basic and clinical research that contribute significant and novel information on the metabolism, transport, and disposition of drugs, therapeutic macromolecules, environmental chemicals and in some instances endogenous compounds. 

Manuscripts on the following topics are encouraged and should highlight important aspects in their cover letter, abstract, and significance statement:

Mechanistic aspects of drug metabolism and transport, including structural studies of enzymes and transporters and biochemical studies of nuclear receptors that regulate drug metabolism and transport
Mechanisms and factors, including genetic, epigenetic, genomic, proteomic, metabolomic, and microbiotic variability, that affect expression and regulation of drug-metabolizing enzymes and transporters
Genetic, nutritional, environmental, or hormonal factors that influence the biological fate of xenobiotics in the body
Impact of xenobiotic metabolism or transport on pharmacokinetics, pharmacodynamics, drug efficacy, drug adverse effects, chemical carcinogenesis or other toxicities, and disease susceptibility
Metabolic studies (e.g., new metabolites, enzymes, pathways, or biomarkers) of important existing drugs (including natural products/herbal drugs, nutritional supplements, and nanocarriers or chemical linkers used in drug formulation), or known toxicants, that address potential clinical or translational significance
ADME studies of new chemical or biological entities that offer new insights into important existing drugs or toxicants, or address mechanisms underlying xenobiotic disposition and response
Clinical pharmacology, pharmacogenomics, drug-drug interaction, and mathematical modeling (PBPK, PKPD, IVIVE) studies that emphasize role of ADME
Novel in vitro and in vivo model systems for ADME studies, such as stem cells, 3-D culture, organs on a chip, transgenic or knockout animal models
Studies of drug metabolism by microbiome or other non-animal species that offer new insights into biological fate of drugs or other xenobiotics in mammals
Novel technologies or experimental methods that can be broadly applied to the study of ADME.
收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息

                                
我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug